Literature DB >> 57337

Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting.

R M Galbraith, A L Eddleston, R Williams, A D Webster, J Pattison, D Doniach, L A Kennedy, J R Batchelor.   

Abstract

Titres of antibodies to rubella, measles, smooth muscle, nuclei, and Escherichia coli were examined in relation to the presence of particular histocompatibility antigens in 57 patients with active chronic hepatitis, 8 of whom were HBsAg positive. With the exception of antibodies to E. Coli, the HBsAg-negative patients with HLA-B8 or HLA-B12 had higher titres than those with neither, and antibody titres were highest in the 7 cases with both these histocompatibility antigens. In contrast, E. coli antibody titres were not related to the presence of particular histocompatibility antigens but correlated closely with the degree of portosystemic shunting. None of the HBsAg-positive patients possessed HLA-B8, and titres of all the antibodies were significantly lower than in the HBsAg-negative cases. The increased antibody response in HBsAg-negative patients is likely to be due to a genetically determined increase in immunological responsiveness for which HLA-B8 and HLA-B12 are markers. The results obtained in healthy family members also suggest that this defect in immunoregulation is under polygenic control.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 57337     DOI: 10.1016/s0140-6736(76)92712-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  Distribution of HLA histocompatibility antigens, ABO blood groups and Rh antigens in alcoholic liver disease.

Authors:  M Meléndez; L Vargas-Tank; C Fuentes; R Armas-Merino; D Castillo; C Wolff; M E Wegmann; J Soto
Journal:  Gut       Date:  1979-04       Impact factor: 23.059

Review 2.  Immunological aspects of liver disease.

Authors:  A L Eddleston; P T Donaldson; J E Hegarty; B D Reed
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 3.  Chronic active hepatitis.

Authors:  P J Johnson; I G McFarlane
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 4.  Autoimmune hepatitis.

Authors:  G Mieli-Vergani; D Vergani
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

5.  Alcoholic liver injury.

Authors:  R Williams; M Davis
Journal:  Proc R Soc Med       Date:  1977-05

6.  Genetically determined immune hyperreactivity in human liver disease.

Authors:  A L Eddleston
Journal:  Proc R Soc Med       Date:  1977-08

7.  Characterization of measles virus-specific antibodies in sera from patients with chronic active hepatitis.

Authors:  K E Christie; C Endresen; G Haukenes
Journal:  J Hyg (Lond)       Date:  1982-06

8.  Differences in intrahepatic portal-systemic shunting in alcoholic and nonalcoholic liver disease as assessed by liver scan, portal pressure, and E. coli antibodies.

Authors:  D R Triger; T D Boyer; A G Redeker; T B Reynolds; A D Waxman
Journal:  Dig Dis Sci       Date:  1979-07       Impact factor: 3.199

9.  Autoantibodies, histocompatibility antigens and testosterone in males with alcoholic liver cirrhosis.

Authors:  C Gluud; U Tage-Jensen; M Bahnsen; O Dietrichson; A Svejgaard
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

10.  HLA frequencies in primary immunodeficiency diseases (pidd).

Authors:  K G Evers; J Krüger; R Hägele; W Haase; B Leven
Journal:  Eur J Pediatr       Date:  1977-02-21       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.